Does Acetaminophen Cause Erectile Dysfunction?

No reliable clinical evidence links acetaminophen (paracetamol) to erectile dysfunction in adult men. Despite being one of the most widely used over-the-counter painkillers in the world, acetaminophen does not appear on standard lists of medications known to impair sexual function, and no human trial has demonstrated a direct connection. The concern surfaces periodically because acetaminophen shares some pharmacological properties with drugs that do raise questions about sexual health, but the actual data tell a reassuring story when you look closely.

Why the Question Comes Up

Acetaminophen works partly by inhibiting cyclooxygenase (COX) enzymes, the same family of enzymes targeted by anti-inflammatory drugs like ibuprofen and naproxen. Because those anti-inflammatory painkillers have been loosely associated with sexual side effects in some studies, people reasonably wonder whether acetaminophen might cause the same problems. Add to that the fact that anyone taking acetaminophen regularly is often dealing with chronic pain, which itself carries a well-documented link to sexual difficulties, and you have a recipe for confusion about what is actually causing what.

A separate thread of concern comes from animal and laboratory research suggesting that acetaminophen can affect hormone levels under certain experimental conditions. These studies get cited in online health forums without much context, leaving the impression that popping a couple of Tylenol might lower testosterone or interfere with erections. The reality is more nuanced, and the distinction between lab findings and real-world outcomes matters here more than usual.

What Lab Research Shows About Erectile Tissue

The most direct way to test whether a drug harms erectile function is to expose penile tissue to the drug and measure what happens. A study that did exactly this with rat erectile tissue found that nonselective COX inhibitors did not impair the tissue’s ability to relax, which is the fundamental mechanical requirement for an erection. The researchers suggested the explanation may be that these drugs block the production of thromboxane A2, a substance that actually promotes contraction of erectile tissue. In other words, blocking COX might, if anything, remove one obstacle to relaxation rather than creating a new one.¹

This is a single laboratory study using animal tissue, so it does not settle the question for humans. But it does push back against the assumption that any drug interfering with prostaglandins will automatically impair erections. Prostaglandins play complicated roles in the body. Some promote erection, others oppose it, and the net effect of blocking the whole family is not as straightforward as it might seem.

The Fetal Testosterone Study and Why It Gets Misread

One study that frequently gets cited in discussions about acetaminophen and male sexual health involved human fetal testicular tissue grafted into mice. When the grafted tissue was exposed to a therapeutic dose of acetaminophen for seven days, plasma testosterone dropped by about 45%, and a biomarker of androgen exposure fell by roughly 18%. Exposure for just one day had no measurable effect. The researchers concluded that prolonged acetaminophen use could suppress fetal testosterone production, with potential consequences for male reproductive development in the womb.²

This study matters for understanding acetaminophen’s effects during pregnancy, but applying it to adult men taking the drug for a headache or sore back requires several leaps. The tissue studied was fetal, not adult. It was transplanted into a mouse, not functioning inside a human body. And the concern was about disrupted development of the reproductive system during a critical window of fetal growth, not about a fully developed adult man losing the ability to get an erection. The biology of testosterone production in a developing fetus is quite different from the hormonal regulation in a grown man whose reproductive system has long since formed. Treating this study as evidence that acetaminophen causes erectile dysfunction in adults misreads both its design and its conclusions.

Chronic Pain as the Hidden Driver

People who take acetaminophen regularly tend to be people living with pain. And pain itself is a major disruptor of sexual function. Research at a multidisciplinary pain management center found a high prevalence of sexual dysfunction among patients with chronic pain, and the severity of both pain and associated psychological distress tracked closely with the degree of sexual difficulty reported.³

This creates a classic confounding problem. If a man with chronic low-back pain takes acetaminophen daily and also experiences erectile difficulty, it is tempting to blame the drug. But the pain itself, the sleep disruption that comes with it, the depression and anxiety that often accompany chronic pain, and the reduced physical activity can all independently impair sexual function. A review of the relationship between chronic pain and erectile dysfunction noted that depression occurring alongside pain raised the risk of ED on its own, with back pain patients who also had depressive disorder facing a meaningfully higher likelihood of erectile problems.⁴

Untangling the drug from the disease it treats is one of the hardest problems in pharmacology, and it is especially tricky with over-the-counter painkillers because so many people take them without formal medical supervision. There is no randomized trial where healthy men were given acetaminophen versus placebo and then assessed for erectile changes, which is the kind of study you would need to pin blame on the drug itself.

Opioids Are the Bigger Concern

When researchers have looked carefully at which pain medications genuinely affect erectile function, opioids stand out. A study of back pain patients found that long-term opioid use was associated with significantly greater use of medications for erectile dysfunction or testosterone replacement compared to patients not on opioids. Among those prescribed higher daily opioid doses, over 19% also received prescriptions for ED medication or testosterone replacement, compared to about 7% of back pain patients not taking opioids at all.⁵

Opioids suppress the hypothalamic-pituitary-gonadal axis, which is the hormonal chain that governs testosterone production. This suppression is dose-dependent and well-documented. Acetaminophen does not have this effect in adults. If you are managing chronic pain and worried about erectile function, the class of painkiller matters enormously, and opioids are the ones with a clear track record of causing problems.⁴

Some combination products contain both acetaminophen and an opioid, such as acetaminophen with codeine or acetaminophen with hydrocodone. If someone taking one of these formulations develops ED, the opioid component is the far more plausible culprit, not the acetaminophen.

How NSAIDs Compare

Anti-inflammatory painkillers like ibuprofen and aspirin are pharmacologically closer to acetaminophen than opioids are, and their relationship with ED has been studied directly. A large analysis using data from the Prostate Cancer Prevention Trial initially found a small increase in ED risk associated with both non-aspirin NSAID use and aspirin use. Non-aspirin NSAIDs were linked to a modest increase in mild-to-moderate ED risk, and aspirin showed a similar-sized link to severe ED. But here is the key finding: those associations weakened and lost statistical significance once the researchers controlled for the reasons people were taking NSAIDs in the first place, such as arthritis, headaches, and cardiovascular disease.⁶

This finding illustrates the confounding problem in a clean way. Men who take NSAIDs regularly tend to have conditions that themselves affect vascular health and sexual function. Once you account for those conditions, the apparent drug effect largely disappears. The study’s authors titled their paper to make the point explicitly: NSAID use is not associated with ED risk. While acetaminophen was not directly tested in that study, it shares some of the same pharmacological profile, and the overall pattern suggests that common over-the-counter analgesics are not the sexual function threat they are sometimes made out to be.

What Pharmacovigilance Data Show

Another way to check whether a drug causes a particular side effect is to look at large-scale adverse event reporting databases. The U.S. Food and Drug Administration maintains one called FAERS (FDA Adverse Event Reporting System), which collects reports from patients, doctors, and manufacturers about suspected side effects. A 2024 study reviewed all erectile dysfunction reports submitted to FAERS between 2004 and 2023 and compiled a list of drugs with disproportionately high ED reporting frequencies.⁷

Pharmacovigilance databases have real limitations. They capture voluntary reports, not controlled experiments, so they cannot prove causation. A drug taken by millions of people will accumulate more reports of every side effect simply because more people are taking it. Still, these databases are useful for flagging unexpected patterns. Drugs with strong signals for ED in FAERS tend to be antidepressants, antihypertensives, hormonal therapies, and certain psychiatric medications. Acetaminophen does not feature as a prominent signal in the ED pharmacovigilance landscape, which is consistent with the rest of the evidence.

Nitric Oxide and Why the Erection Pathway Is Mostly Unaffected

Erections depend on nitric oxide (NO) signaling. When a man becomes sexually aroused, nerves and blood vessel linings in the penis release NO, which triggers a molecular chain reaction that relaxes smooth muscle and allows blood to flow in. The key messenger molecule in this chain is cGMP. Drugs like sildenafil (Viagra) work by protecting cGMP from being broken down too quickly.

Acetaminophen’s main pharmacological actions do not intersect with this pathway in any meaningful way. It does not block nitric oxide production, does not interfere with cGMP signaling, and does not constrict penile blood vessels. Research into compounds that enhance penile tissue relaxation through the NO-cGMP pathway has shown that certain nitrogen- and sulfur-containing molecules can dramatically boost cGMP levels and improve relaxation responses in human erectile tissue.⁸ These findings are about developing new treatments for ED, not about acetaminophen, but they help illustrate the biochemical machinery involved. The point is that the pathway governing erections is well mapped, and acetaminophen does not disrupt any of its major steps.

Practical Considerations if You Are Worried

If you take acetaminophen occasionally for headaches, minor aches, or fever, the available evidence gives no reason to worry about your erectile function. There is no clinical study, no significant pharmacovigilance signal, and no mechanistic reason to think standard use of acetaminophen causes ED in adult men.

If you are taking acetaminophen regularly for chronic pain and also experiencing erectile difficulties, the most productive step is to consider the full picture with your doctor. Questions worth raising include:

Pain itself: Is your pain being managed well enough to allow normal physical activity and sleep?
Other medications: Are you also taking opioids, antidepressants, blood pressure medications, or other drugs that have established links to ED?
Mood and stress: Chronic pain frequently brings depression and anxiety, both of which can independently impair sexual function.
Vascular health: Conditions like diabetes, high blood pressure, and high cholesterol affect the blood vessels that erections depend on, and they also tend to cause pain conditions that lead to more analgesic use.

Blaming acetaminophen for ED, when any of the factors above could be responsible, risks pulling your attention away from issues that are both more likely causes and more treatable.

Acetaminophen Versus Other Common Drug Classes

Putting acetaminophen in context alongside drug classes that genuinely do affect erectile function helps calibrate the risk. Certain blood pressure medications, particularly older beta-blockers and thiazide diuretics, have decades of evidence linking them to ED. SSRIs and other antidepressants are well known for sexual side effects across multiple domains, including desire, arousal, and orgasm. As noted earlier, opioids suppress testosterone in a dose-dependent fashion and are clearly associated with increased ED medication use.⁵ Finasteride, used for hair loss and enlarged prostate, has generated its own extensive debate about persistent sexual side effects.

Acetaminophen does not belong in any of these categories. It does not affect the hormonal axis in adult men the way opioids do. It does not alter serotonin signaling the way antidepressants do. It does not block adrenergic receptors the way beta-blockers do. Its pharmacological profile simply does not include the mechanisms that produce drug-induced ED.

That said, no drug is perfectly inert, and individual reactions can always surprise. If you notice a temporal pattern between starting or increasing acetaminophen and developing erectile difficulties, mention it to your doctor. The explanation is likely to be found elsewhere, but tracking the timing is still useful information for sorting out what is going on.

The Gap Between Animal Research and Human Experience

A recurring theme in online discussions about acetaminophen and male sexual health is the selective citation of animal studies. Beyond the fetal testosterone study discussed earlier, there are rodent experiments examining acetaminophen’s effects on testicular tissue, sperm parameters, and oxidative stress markers in reproductive organs. Some of these show concerning results at high doses or with prolonged exposure.

The trouble is that animal reproductive toxicology studies are designed to probe the outer boundaries of what a drug can do under extreme conditions. Doses are often much higher relative to body weight than what a human would take, exposure durations can span most of the animal’s reproductive lifespan, and the biological differences between rodent and human reproductive systems are substantial. These studies are valuable for identifying hazards that deserve further investigation, but they are not evidence that the drug causes the same effects in people taking normal doses. The history of pharmacology is full of compounds that produced dramatic effects in rodent reproductive studies but showed no equivalent problems in human use, and vice versa.

For acetaminophen specifically, the gap between animal findings and human clinical experience is wide. Billions of doses are taken annually worldwide, and no pattern of erectile dysfunction has emerged from decades of use, clinical trials of other conditions that happened to track side effects, or pharmacovigilance monitoring. If acetaminophen caused ED at anything close to the rates implied by some rodent studies, the signal would have surfaced long ago.